Literature DB >> 17041363

Sudden death in rheumatoid arthritis: pulmonary embolism--a fatal complication of iliopsoas bursitis.

George E McLaughlin1.   

Abstract

Sudden death resulting from embolic complications of iliopsoas bursitis has not been previously reported. This case report deals with a 48-year-old woman with seropositive rheumatoid arthritis who presented with symptoms suggestive of deep vein thrombosis. She was found to have complete occlusion of the femoral vein secondary to iliopsoas bursal inflammation and swelling. She died suddenly. At autopsy, a large pulmonary embolism was identified as the cause of death. This report should increase awareness of the incidence of iliopsoas bursitis in rheumatoid arthritis and its potential danger. Early and aggressive management approaches described herein might have prevented this fatality.

Entities:  

Year:  2002        PMID: 17041363

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN: 1076-1608            Impact factor:   3.517


  4 in total

1.  Alterations of the thrombin generation profile in rheumatoid arthritis.

Authors:  Anita Kern; Attila Balog; Sonja Dulic; Eszter Barabás; Mária Kiszelák; Barna Vásárhelyi
Journal:  J Thromb Thrombolysis       Date:  2016-04       Impact factor: 2.300

Review 2.  Risk of venous thromboembolism in patients with rheumatoid arthritis: a systematic review and meta-analysis.

Authors:  Patompong Ungprasert; Narat Srivali; Ittikorn Spanuchart; Charat Thongprayoon; Eric L Knight
Journal:  Clin Rheumatol       Date:  2014-01-15       Impact factor: 2.980

3.  Abductor muscle necrosis due to iliopsoas bursal mass after total hip arthroplasty.

Authors:  Christopher J DeFrancesco; Atul F Kamath
Journal:  J Clin Orthop Trauma       Date:  2015-06-04

4.  Leg lymphedema caused by iliopectineal bursitis associated with destruction of a rheumatoid hip joint: A case report.

Authors:  Gen Kuroyanagi; Kunio Yamada; Tsukasa Imaizumi; Jun Mizutani; Ikuo Wada; Osamu Kozawa; Haruhiko Tokuda; Takanobu Otsuka
Journal:  Exp Ther Med       Date:  2013-08-02       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.